Press Release
Select category
  • Select category
  • Aerospace & Defense
    • Aircraft Components
    • Aircraft Material
    • Aviation
    • Defense
    • Marine
    • Security
    • Space
    • Technology
  • Agriculture
    • Materials
    • Technology
  • Automotive
    • Automotive Systems
    • Chemical Automotive
    • Component
    • Freight & Logistics
    • Material
    • Technology
    • Transport Mode
    • Utility
    • Vehicle
  • Automotive (CI)
  • Baby Products and supplies
  • BFSI
    • Banking
  • Chemical and Materials
    • Advanced Materials
    • Chemical
    • Coatings and Additives
    • Composites
    • Paints
    • Textile
  • Chemical and Materials (CI)
  • Construction & Manufacturing
    • Agriculture
    • Construction and Improvements
    • Construction Materials
    • Decor
    • Equipment and Machinery
    • Industrial Equipment & Automation
    • Packaging
  • Construction & Manufacturing (CI)
  • Consumer & Goods
    • Baby products and supplies
    • Beauty & Personal Care
    • Consumer
    • Home Products
    • Retail
    • Sports & Fitness
    • Travel
  • Electronics and Semiconductor
    • Communication Equipment
    • Display Technology
    • Electronic Component
    • Electronic Devices
    • Emerging Technologies
    • Security
    • Semiconductor
    • Sensor & Control
    • Technology
  • Electronics and Semiconductor (CI)
  • Energy and Power
    • Conventional Energy
    • Equipment
    • Power
    • Renewable Energy
    • Services
    • Storage and Distribution
    • Technology
    • Utility
  • Energy and Power (CI)
  • Food & Beverage
    • Baby Food
    • Beverages
    • Dairy Products
    • Food Ingredient
    • Food Products
    • Food Services and Hospitality
    • Packaging
    • Processed Food
  • Healthcare
  • Healthcare (CI)
  • Industrial Automation & Equipment
    • Component
  • Information and Communication Technology
    • Communication
    • Data Center
    • Data Center and Networking
    • Emerging Technologies
    • Entertainment Technologies
    • Security
    • Software and Services
    • Technology
  • Information and Communication Technology ICT (CI)
  • Life Science
    • Biotechnology
    • Diagnostics and Biotech
    • Healthcare Equipment
    • Healthcare IT
    • Medical Devices
    • Packaging
    • Pharmaceutical
    • Therapeutic
  • Miscellaneous
    • BFSI
    • Education and Training
  • Uncategorized
Evolve Business Intelligence Evolve Business Intelligence
  • Home
  • About Us
  • Services
  • Market Reports
    • Automotive
      • Component
      • Vehicle
      • Chemical Automotive
      • Technology
      • Freight & Logistics
      • Material
      • Technology
      • Transport Mode
      • Utility
      • Vehicle
    • Chemical and Materials
      • Chemical
      • Advanced Materials
      • Coatings and Additives
      • Composites
      • Paints
      • Textile
    • Aerospace & Defense
      • Marine
      • Security
      • Technology
      • Aircraft Components
      • Aircraft Material
    • Construction & Manufacturing
    • Electronics and Semiconductor
      • Display Technology
      • Electronic Component
      • Electronic Devices
      • Semiconductor
      • Communication Equipment
      • Emerging Technologies
      • Security
      • Sensor & Control
      • Technology
    • Energy and Power
    • Life Science
    • Consumer & Goods
      • Baby products and supplies
      • Beauty & Personal Care
      • Consumer
      • Home Products
    • Information and Communication Technology
      • Emerging Technologies
      • Entertainment Technologies
      • Security
      • Communication
      • Data Center
      • Data Center and Networking
      • Software and Services
      • Technology
  • Competitive Intelligence (CI)
    • Automotive (CI)
    • Chemical and Materials (CI)
    • Construction & Manufacturing (CI)
    • Energy and Power (CI)
    • Electronics and Semiconductor (CI)
    • Healthcare (CI)
    • Information and Communication Technology ICT (CI)
  • Contact Us
Menu
Evolve Business Intelligence Evolve Business Intelligence
Press Release
Life Science
Click to enlarge
Home » Our Report Repository » Cell Therapy Market Analysis and Global Forecast (2023-2033) with COVID Impact Analysis
Automotive Market research
Automotive Substrates Market Analysis and Global Forecast (2023-2033) with COVID Impact Analysis $4,745.60(Approx. $ 3,475.00)
Back to products
Corporate Wellness Market Analysis and Global Forecast (2023-2033) with COVID Impact Analysis $4,745.60(Approx. $ 3,475.00)

Cell Therapy Market Analysis and Global Forecast (2023-2033) with COVID Impact Analysis

$4,745.60(Approx. $ 3,475.00)

Cell Therapy Market Research Report: By Cell Type (Stem Cell, Non-stem Cell), By Therapy Type (Autologous, Allogeneic), By Therapeutic Area (Malignancies, Musculoskeletal Disorders, Autoimmune Disorders, Dermatology, Others), and by Region — Forecast till 2033

Categories: Diagnostics and Biotech, Healthcare IT, Life Science
Share:
  • Description
  • Table of Content
  • Connect to Analyst
  • Research Methodology
Description

Cell Therapy Market Overview

The Cell Therapy Market Size is expected to reach USD 45.61 Billion by 2033. The Cell Therapy industry size accounted for USD 4.77 Billion in 2023 and is expected to expand at a compound annual growth rate (CAGR) of 16.5% from 2023 to 2033. Cell therapy, also known as cellular therapy or regenerative medicine, refers to a form of medical treatment that involves the use of living cells to treat or potentially cure various diseases and conditions. It aims to restore or replace damaged, dysfunctional, or missing cells within the body. Cell therapy typically involves the isolation, manipulation, and administration of cells to the patient to repair or regenerate the affected tissues or organs. The cells used in this type of therapy can be derived from various sources, including the patient’s cells (autologous), cells from a compatible donor (allogeneic), or even genetically modified cells.

Global Cell Therapy Market Synopsis

COVID-19 Impact Analysis

The COVID-19 pandemic had a profound effect on the Cell Therapy market. While the pandemic posed significant challenges to healthcare systems worldwide, it also highlighted the potential of cell therapy in addressing critical medical needs. The urgent demand for effective treatments and vaccines against COVID-19 accelerated research and development in cell-based therapies, such as convalescent plasma therapy and mesenchymal stem cell therapy, for treating severe cases and modulating the immune response. Additionally, the pandemic led to increased investments in cell therapy research, manufacturing capabilities, and infrastructure, as well as regulatory adaptations to facilitate the development and deployment of novel cell-based treatments. Despite disruptions in clinical trials and supply chains, the pandemic has spurred innovation and collaboration, positioning the Cell Therapy market for continued growth and advancements in the post-pandemic era.

Global Cell Therapy Market Dynamics

The major factors that have impacted the growth of Cell Therapy are as follows:

Drivers:

Increasing prevalence of chronic diseases

The rising prevalence of chronic diseases, such as cancer, cardiovascular disorders, and neurodegenerative conditions, is a significant driver for the cell therapy market. Cell therapy offers potential solutions by providing regenerative and immunotherapeutic approaches to treat or manage these diseases. The increasing burden of chronic diseases worldwide has created a demand for innovative therapies, driving the growth of the cell therapy market.

Restraint:

  • High costs and reimbursement challenges

One of the key restraints for the cell therapy market is the high costs associated with research, development, and manufacturing of cell-based therapies. The complex and specialized nature of cell therapies often requires extensive resources and infrastructure, contributing to their high price tags. Additionally, reimbursement challenges and uncertainties surrounding the coverage and reimbursement policies by healthcare systems pose barriers to the widespread adoption of cell therapies, limiting patient access to these innovative treatments.

Opportunity:

Advancements in stem cell research and genetic engineering

The field of stem cell research and genetic engineering holds significant opportunities for the cell therapy market. Advances in understanding stem cell biology, including the development of induced pluripotent stem cells (iPSCs), have expanded the potential applications of cell therapy. iPSCs offer the possibility of generating patient-specific cells, minimizing immune rejection, and enabling personalized therapies. Moreover, breakthroughs in genetic engineering techniques, such as CRISPR-Cas9, have opened new avenues for modifying cells to enhance their therapeutic properties, leading to improved efficacy and safety of cell-based treatments. These advancements present promising opportunities for the development of next-generation cell therapies.

Cell Therapy Market Segment Overview

By Cell Type

Based on the Cell Type, the market is segmented based on Stem Cells, Non-stem Cell. The Stem Cell segment was projected to hold the largest market share in the Cell Therapy market. Stem cells possess the unique ability to self-renew and differentiate into various specialized cell types, making them a valuable resource for regenerative medicine and cell-based therapies. Stem cells can be derived from various sources, including embryonic stem cells, adult stem cells, and induced pluripotent stem cells (iPSCs).

By Therapy Type

Based on Therapy Type, the market has been divided into Autologous, Allogeneic. The Autologous segment is expected to hold the largest market share in the Market. Autologous cell therapies are custom-made for each patient, increasing the likelihood of compatibility and reducing the need for immunosuppressive drugs. Additionally, the availability of a patient’s cells eliminates the need for finding suitable donors and mitigates ethical concerns associated with allogeneic (donor-derived) cell therapies.

By Therapeutic Area

Based on the Therapeutic Area, the market has been divided into Malignancies, Musculoskeletal Disorders, Autoimmune Disorders, Dermatology, and Others. The Malignancies segment is projected to experience significant growth in the Cell Therapy market. Cell therapies have shown promising results in the treatment of various malignancies, including hematological cancers (such as leukemia and lymphoma) and solid tumors (such as melanoma and lung cancer). Chimeric Antigen Receptor (CAR) T-cell therapy, a type of cell therapy, has emerged as a breakthrough treatment for certain malignancies. CAR T-cell therapy involves genetically modifying a patient’s T cells to express specific receptors (CARs) that recognize and target cancer cells. This approach has demonstrated remarkable efficacy in certain hematological malignancies, such as acute lymphoblastic leukemia (ALL) and diffuse large B-cell lymphoma (DLBCL).

Global Cell Therapy Market Regional Analysis

Based on region, the market has been divided into North America, Europe, Asia-Pacific, the Middle East & Africa, and Latin America. The area of North America is anticipated to dominate the market for the usage of Cell Therapy, followed by those in Asia-Pacific and Europe.

North America Market

North America has consistently held the largest market share in the Cell Therapy market due to several factors. The region benefits from a well-established healthcare infrastructure, including advanced research facilities and clinical centers, which facilitate the development and adoption of cell therapies. Additionally, the favorable regulatory environment, particularly in the United States, with initiatives like the RMAT designation and breakthrough therapy designation, expedites the approval process for cell therapies. North America also boasts strong research and development activities, driven by leading institutions and biotechnology companies, which contribute to advancements in the field. These factors collectively attract investments, foster innovation, and position North America as a dominant player in the Cell Therapy market.

Asia Pacific Market

The Cell Therapy industry in the Asia-Pacific region has been experiencing remarkable growth. Several factors contribute to this expansion. First, the region has a large patient population, including a significant number of individuals with chronic diseases such as cancer and cardiovascular disorders, creating a demand for innovative therapies. Additionally, countries in the Asia-Pacific region, such as China, Japan, and South Korea, have made substantial investments in research and development, infrastructure, and manufacturing capabilities, fostering a supportive ecosystem for cell therapy advancements. Moreover, the region benefits from a comparatively lower cost of conducting clinical trials and manufacturing, attracting global companies to establish collaborations and expand their operations in the region. These factors, combined with the region’s increasing focus on healthcare advancements, are propelling the growth of the Cell Therapy industry in the Asia-Pacific region.

Competitive Landscape

The competitive landscape includes key players (tier 1, tier 2, and local) having a presence across the globe. Companies such as Novartis AG, Gilead Sciences Inc, Bristol-Myers Squibb Company, Johnson & Johnson Services Inc, and JCR Pharmaceuticals Co Ltd are some of the leading players in the global  Cell Therapy Industry. These players have adopted partnership, acquisition, expansion, and new product development, among others as their key strategies.

Key Market Players:

  • Novartis AG
  • Gilead Sciences Inc
  • Bristol-Myers Squibb Company
  • Johnson & Johnson Services Inc
  • JCR Pharmaceuticals Co Ltd
  • Tego Science
  • Atara Biotherapeutics
  • Takeda Pharmaceutical Company Limited
  • Bluebird Bio Inc
  • Dendreon Corp

Key development:

In January 2022, Immunocore received the Food and Drug Administration approval of KIMMTRAK (tebentafusp-tebn) for the treatment of unresectable or metastatic uveal melanoma.

In March 2021, Novadip Biosciences secured Investigational New Drug (IND) approval from the FDA for their regenerative bone product NVD-003, designed specifically for treating rare pediatric bone disease.

Scope of the Report

Global Cell Therapy Market, by Cell Type

  • Stem Cell
  • Non-stem Cell

Global Cell Therapy Market, by Therapy Type

  • Autologous
  • Allogeneic

Global Cell Therapy Market, by Therapeutic Area

  • Malignancies
  • Musculoskeletal Disorders
  • Autoimmune Disorders
  • Dermatology
  • Others

Global Cell Therapy Market, by Region

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Benelux
    • Nordic
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • Indonesia
    • Austalia
    • Malaysia
    • India
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • South Africa
    • Rest of Middle East & Africa

 

Parameters Indicators
Market Size 2033: $45.61 Billion
CAGR 16.5% CAGR (2023-2033)
Base year 2022
Forecast Period 2023-2033
Historical Data 2021
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Key Segmentations Cell Type, Therapy Type, Therapeutic Area
Geographies Covered North America, Europe, Asia-Pacific, Latin America, Middle East, Africa
Key Vendors Novartis AG, Gilead Sciences Inc, Bristol-Myers Squibb Company, Johnson & Johnson Services Inc, JCR Pharmaceuticals Co Ltd, Tego Science, Atara Biotherapeutics, Takeda Pharmaceutical Company Limited, Bluebird Bio Inc, Dendreon Corp
Key Market Opportunities • Growing regulatory support and streamlined approvals
• Advancements in personalized medicine
Key Market Drivers • Increasing investment and funding
• Increasing prevalence of chronic diseases

 

REPORT CONTENT BRIEF:

  • High-level analysis of the current and future Cell Therapy Industry trends and opportunities
  • Detailed analysis of current market drivers, restraining factors, and opportunities analysis in the future
  • Historical market size for the year 2021, and forecast from 2023 to 2033
  • Cell Therapy market share analysis for each segment
  • Competitor analysis with a comprehensive insight into its product segment, financial strength, and strategies adopted.
  • Identifies key strategies adopted by the key players including new product development, mergers and acquisitions, joint ventures, collaborations, and partnerships.
  • To identify and understand the various factors involved in the global Cell Therapy market affected by the pandemic
  • To provide year-on-year growth from 2022 to 2033
  • To provide short-term, long-term, and overall CAGR comparison from 2022 to 2033.
  • Provide Total Addressable Market (TAM) for the Global Cell Therapy Market.

Frequently Asked Questions (FAQ)

For more details mail us at

[email protected]

Ask a question / additional requirement

Press Release

  • The Global Double Chamber Injection Devices Market Is Estimated To Record a CAGR of Around 9.99% During The Forecast Period

    The Global Double Chamber Injection Devices Market Is Estimated To Record a CAGR of Around 9.99% During The Forecast Period

    August 26, 2023

  • The Global Flexible Printed Circuit Board Market Is Estimated To Record a CAGR of Around 11.60% During The Forecast Period

    The Global Flexible Printed Circuit Board Market Is Estimated To Record a CAGR of Around 11.60% During The Forecast Period

    August 26, 2023

  • The Global Clinical Biomarkers Market Is Estimated To Record a CAGR of Around 16.7% During The Forecast Period

    The Global Clinical Biomarkers Market Is Estimated To Record a CAGR of Around 16.7% During The Forecast Period

    August 26, 2023

  • The Global Data Center Environmental Monitoring System Market Is Estimated To Record a CAGR of Around 8.45% During The Forecast Period

    The Global Data Center Environmental Monitoring System Market Is Estimated To Record a CAGR of Around 8.45% During The Forecast Period

    August 26, 2023

  • The Global Data Center Networking Market Is Estimated To Record a CAGR of Around 15.55% During The Forecast Period

    The Global Data Center Networking Market Is Estimated To Record a CAGR of Around 15.55% During The Forecast Period

    August 26, 2023

  • The Global Graft Delivery Device Market Is Estimated To Record a CAGR of Around 12.99% During The Forecast Period

    The Global Graft Delivery Device Market Is Estimated To Record a CAGR of Around 12.99% During The Forecast Period

    August 26, 2023

  • The Global HubSpot Consulting and Implementation Market Is Estimated To Record a CAGR of Around 15.23% During The Forecast Period

    The Global HubSpot Consulting and Implementation Market Is Estimated To Record a CAGR of Around 15.23% During The Forecast Period

    August 26, 2023

  • The Global Liquid Skin Protectors Market Is Estimated To Record a CAGR of Around 10.64% During The Forecast Period

    The Global Liquid Skin Protectors Market Is Estimated To Record a CAGR of Around 10.64% During The Forecast Period

    August 26, 2023

  • The Global Lithium-Ion Battery Energy Storage System Market Is Estimated To Record a CAGR of Around 15.5% During The Forecast Period

    The Global Lithium-Ion Battery Energy Storage System Market Is Estimated To Record a CAGR of Around 15.5% During The Forecast Period

    August 26, 2023

  • The Global Machine Safety Market Is Estimated To Record a CAGR of Around 6.9% During The Forecast Period

    The Global Machine Safety Market Is Estimated To Record a CAGR of Around 6.9% During The Forecast Period

    August 26, 2023

1. What is the study period of this market?

  • The study period of the global Cell Therapy market is 2022- 2033

2. What are the 10 Years CAGR (2023 to 2033) of the global Cell Therapy market?

  • The global Cell Therapy market is growing at a CAGR of ~5% over the next 10 years

3. Which region has the highest growth rate in the market of Cell Therapy?

  • Asia Pacific is expected to register the highest CAGR during 2023-2033

4. Which region accounted for the largest share of the market of Cell Therapy?

  • North America holds the largest share in 2022

5. Major Key Players in the Market of Stem Cell Manufacturers?

  • Novartis AG, Gilead Sciences Inc, Bristol-Myers Squibb Company, Johnson & Johnson Services Inc, JCR Pharmaceuticals Co Ltd, Tego Science, Atara Biotherapeutics, Takeda Pharmaceutical Company Limited, Bluebird Bio Inc, Dendreon Corp are the major companies operating in the Cell Therapy

6. Do you offer Post Sale Support?

  • Yes, we offer 16 hours of analyst support to solve the queries

7. Do you deliver sections of a report?

Yes, we do provide regional as well as country-level reports. Other than this we also provide a sectional report. Please get in contact with our sales representatives.

Table of Content

Table of Content

CHAPTER 1.                 Executive Summary

CHAPTER 2.                 Scope of the Study

2.1.        Market Definition

2.2.        Market Scope & Segmentation

2.2.1.         Objective of Report

CHAPTER 3.                 Evolve BI Methodology

3.1.        Data Collection & Validation Approach

3.2.        Market Size Estimation and Forecast

CHAPTER 4.                 Exclusive Analysis

4.1.        Market Opportunity Score

4.1.1.         Cell Type Segement – Market Opportunity Score

4.1.2.         Therapy Type Segment – Market Opportunity Score

4.1.3.         Therapeutic Area Segment – Market Opportunity Score

4.2.        Key Market Influencing Indicators

CHAPTER 5.                 Market Insights and Trends

5.1.        Value Chain Analysis

5.1.1.         Raw Material

5.1.2.         Manufacturing Process

5.1.3.         Distribution Channel

5.1.4.         End User

5.2.        Porter’s Five Forces Analysis

5.2.1.         Bargaining Power of Buyers

5.2.2.         Bargaining Power of Suppliers

5.2.3.         Threat of New Entrant

5.2.4.         Threat of Substitute

5.2.5.         Industry Rivalry

5.3.        COVID-19 Impact and Post COVID Scenario on Cell Therapy Market

5.3.1.         Impact of COVID-19

5.3.2.         Government Support and Industry Revival Policies

5.3.3.         Measures Taken by Companies to Mitigate Negative Impact

5.3.4.         Post COVID Trend

CHAPTER 6.                 MArket Dynamics

6.1.        Introduction

6.2.        Drivers

6.2.1.         Driver 1

6.2.2.         Driver 2

6.2.3.         Driver 3

6.3.        Restraints

6.3.1.         Restraint 1

6.3.2.         Restraint 2

6.4.        Opportunity

6.4.1.         Opportunity 1

CHAPTER 7.                 Global Cell Therapy Market, By Cell Type

7.1.        Introduction

7.1.1.         Stem Cell

7.1.2.         Non-stem Cell

CHAPTER 8.                 Global Cell Therapy Market, By Therapy Type

8.1.        Introduction

8.1.1.         Autologous

8.1.2.         Allogeneic

CHAPTER 9.                 Global Cell Therapy Market, By Therapeutic Area

9.1.        Introduction

9.1.1.         Malignancies

9.1.2.         Musculoskeletal Disorders

9.1.3.         Autoimmune Disorders

9.1.4.         Dermatology

9.1.5.         Others

CHAPTER 10.               Global Cell Therapy Market, By Region

10.1.     Introduction

10.2.     NORTH AMERICA

10.2.1.      North America: Market Size and Forecast, By Country, 2023 – 2033 ($ Million)

10.2.2.      North America: Market Size and Forecast, By Cell Type, 2023 – 2033 ($ Million)

10.2.3.      North America: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million)

10.2.4.      North America: Market Size and Forecast, By Therapeutic Area, 2023 – 2033 ($ Million)

10.2.5.      US

10.2.5.1.       US: Market Size and Forecast, By Cell Type, 2023 – 2033 ($ Million)

10.2.5.2.       US: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million)

10.2.5.3.       US: Market Size and Forecast, By Therapeutic Area, 2023 – 2033 ($ Million)

10.2.6.      CANADA

10.2.6.1.       Canada: Market Size and Forecast, By Cell Type, 2023 – 2033 ($ Million)

10.2.6.2.       Canada: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million)

10.2.6.3.       Canada: Market Size and Forecast, By Therapeutic Area, 2023 – 2033 ($ Million)

10.2.7.      MEXICO

10.2.7.1.       Mexico: Market Size and Forecast, By Cell Type, 2023 – 2033 ($ Million)

10.2.7.2.       Mexico: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million)

10.2.7.3.       Mexico: Market Size and Forecast, By Therapeutic Area, 2023 – 2033 ($ Million)

10.3.     Europe

10.3.1.      Europe: Market Size and Forecast, By Country, 2023 – 2033 ($ Million)

10.3.2.      Europe: Market Size and Forecast, By Cell Type, 2023 – 2033 ($ Million)

10.3.3.      Europe: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million)

10.3.4.      Europe: Market Size and Forecast, By Therapeutic Area, 2023 – 2033 ($ Million)

10.3.5.      U.K.

10.3.5.1.       U.K.: Market Size and Forecast, By Cell Type, 2023 – 2033 ($ Million)

10.3.5.2.       U.K.: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million)

10.3.5.3.       U.K.: Market Size and Forecast, By Therapeutic Area, 2023 – 2033 ($ Million)

10.3.6.      GERMANY

10.3.6.1.       Germany: Market Size and Forecast, By Cell Type, 2023 – 2033 ($ Million)

10.3.6.2.       Germany: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million)

10.3.6.3.       Germany: Market Size and Forecast, By Therapeutic Area, 2023 – 2033 ($ Million)

10.3.7.      FRANCE

10.3.7.1.       France: Market Size and Forecast, By Cell Type, 2023 – 2033 ($ Million)

10.3.7.2.       France: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million)

10.3.7.3.       France: Market Size and Forecast, By Therapeutic Area, 2023 – 2033 ($ Million)

10.3.8.      ITALY

10.3.8.1.       Italy: Market Size and Forecast, By Cell Type, 2023 – 2033 ($ Million)

10.3.8.2.       Italy: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million)

10.3.8.3.       Italy: Market Size and Forecast, By Therapeutic Area, 2023 – 2033 ($ Million)

10.3.9.           SPAIN

10.3.9.1.        Spain: Market Size and Forecast, By Cell Type, 2023 – 2033 ($ Million)

10.3.9.2.        Spain: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million)

10.3.9.3.        Spain: Market Size and Forecast, By Therapeutic Area, 2023 – 2033 ($ Million)

10.3.10.         BENELUX

10.3.10.1.     BeNeLux: Market Size and Forecast, By Cell Type, 2023 – 2033 ($ Million)

10.3.10.2.     BeNeLux: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million)

10.3.10.3.     BeNeLux: Market Size and Forecast, By Therapeutic Area, 2023 – 2033 ($ Million)

10.3.11.         RUSSIA

10.3.11.1.     Russia: Market Size and Forecast, By Cell Type, 2023 – 2033 ($ Million)

10.3.11.2.     Russia: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million)

10.3.11.3.     Russia: Market Size and Forecast, By Therapeutic Area, 2023 – 2033 ($ Million)

10.3.12.         REST OF EUROPE

10.3.12.1.     Rest of Europe: Market Size and Forecast, By Cell Type, 2023 – 2033 ($ Million)

10.3.12.2.     Rest of Europe: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million)

10.3.12.3.     Rest of Europe: Market Size and Forecast, By Therapeutic Area, 2023 – 2033 ($ Million)

10.4.     Asia Pacific

10.4.1.      Asia Pacific: Market Size and Forecast, By Country, 2023 – 2033 ($ Million)

10.4.2.      Asia Pacific: Market Size and Forecast, By Cell Type, 2023 – 2033 ($ Million)

10.4.3.      Asia Pacific: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million)

10.4.4.      Asia Pacific: Market Size and Forecast, By Therapeutic Area, 2023 – 2033 ($ Million)

10.4.5.      CHINA

10.4.5.1.       China: Market Size and Forecast, By Cell Type, 2023 – 2033 ($ Million)

10.4.5.2.       China: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million)

10.4.5.3.       China: Market Size and Forecast, By Therapeutic Area, 2023 – 2033 ($ Million)

10.4.6.      JAPAN

10.4.6.1.       Japan: Market Size and Forecast, By Cell Type, 2023 – 2033 ($ Million)

10.4.6.2.       Japan: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million)

10.4.6.3.       Japan: Market Size and Forecast, By Therapeutic Area, 2023 – 2033 ($ Million)

10.4.7.      INDIA

10.4.7.1.       India: Market Size and Forecast, By Cell Type, 2023 – 2033 ($ Million)

10.4.7.2.       India: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million)

10.4.7.3.       India: Market Size and Forecast, By Therapeutic Area, 2023 – 2033 ($ Million)

10.4.8.      SOUTH KOREA

10.4.8.1.       South Korea: Market Size and Forecast, By Cell Type, 2023 – 2033 ($ Million)

10.4.8.2.       South Korea: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million)

10.4.8.3.       South Korea: Market Size and Forecast, By Therapeutic Area, 2023 – 2033 ($ Million)

10.4.9.           THAILAND

10.4.9.1.        Thailand: Market Size and Forecast, By Cell Type, 2023 – 2033 ($ Million)

10.4.9.2.        Thailand: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million)

10.4.9.3.        Thailand: Market Size and Forecast, By Therapeutic Area, 2023 – 2033 ($ Million)

10.4.10.         INDONESIA

10.4.10.1.     Indonesia: Market Size and Forecast, By Cell Type, 2023 – 2033 ($ Million)

10.4.10.2.     Indonesia: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million)

10.4.10.3.     Indonesia: Market Size and Forecast, By Therapeutic Area, 2023 – 2033 ($ Million)

10.4.11.         MALAYSIA

10.4.11.1.     Malaysia: Market Size and Forecast, By Cell Type, 2023 – 2033 ($ Million)

10.4.11.2.     Malaysia: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million)

10.4.11.3.     Malaysia: Market Size and Forecast, By Therapeutic Area, 2023 – 2033 ($ Million)

10.4.12.         AUSTRALIA

10.4.12.1.     Australia: Market Size and Forecast, By Cell Type, 2023 – 2033 ($ Million)

10.4.12.2.     Australia: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million)

10.4.12.3.     Australia: Market Size and Forecast, By Therapeutic Area, 2023 – 2033 ($ Million)

10.4.13.         REST FO ASIA PACIFIC

10.4.13.1.     Rest fo Asia Pacific: Market Size and Forecast, By Cell Type, 2023 – 2033 ($ Million)

10.4.13.2.     Rest fo Asia Pacific: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million)

10.4.13.3.     Rest fo Asia Pacific: Market Size and Forecast, By Therapeutic Area, 2023 – 2033 ($ Million)

10.5.     South America

10.5.1.      South America: Market Size and Forecast, By Country, 2023 – 2033 ($ Million)

10.5.2.      South America: Market Size and Forecast, By Cell Type, 2023 – 2033 ($ Million)

10.5.3.      South America: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million)

10.5.4.      South America: Market Size and Forecast, By Therapeutic Area, 2023 – 2033 ($ Million)

10.5.5.      BRAZIL

10.5.5.1.       Brazil: Market Size and Forecast, By Cell Type, 2023 – 2033 ($ Million)

10.5.5.2.       Brazil: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million)

10.5.5.3.       Brazil: Market Size and Forecast, By Therapeutic Area, 2023 – 2033 ($ Million)

10.5.6.      ARGENTINA

10.5.6.1.       Argentina: Market Size and Forecast, By Cell Type, 2023 – 2033 ($ Million)

10.5.6.2.       Argentina: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million)

10.5.6.3.       Argentina: Market Size and Forecast, By Therapeutic Area, 2023 – 2033 ($ Million)

10.5.7.      REST OF SOUTH AMERICA

10.5.7.1.       Rest of South America: Market Size and Forecast, By Cell Type, 2023 – 2033 ($ Million)

10.5.7.2.       Rest of South America: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million)

10.5.7.3.       Rest of South America: Market Size and Forecast, By Therapeutic Area, 2023 – 2033 ($ Million)

10.6.     Middle East & Africa

10.6.1.      Middle East & Africa: Market Size and Forecast, By Country, 2023 – 2033 ($ Million)

10.6.2.      Middle East & Africa: Market Size and Forecast, By Cell Type, 2023 – 2033 ($ Million)

10.6.3.      Middle East & Africa: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million)

10.6.4.      Middle East & Africa: Market Size and Forecast, By Therapeutic Area, 2023 – 2033 ($ Million)

10.6.5.      SAUDI ARABIA

10.6.5.1.       Saudi Arabia: Market Size and Forecast, By Cell Type, 2023 – 2033 ($ Million)

10.6.5.2.       Saudi Arabia: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million)

10.6.5.3.       Saudi Arabia: Market Size and Forecast, By Therapeutic Area, 2023 – 2033 ($ Million)

10.6.6.      UAE

10.6.6.1.       UAE: Market Size and Forecast, By Cell Type, 2023 – 2033 ($ Million)

10.6.6.2.       UAE: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million)

10.6.6.3.       UAE: Market Size and Forecast, By Therapeutic Area, 2023 – 2033 ($ Million)

10.6.7.      EGYPT

10.6.7.1.       Egypt: Market Size and Forecast, By Cell Type, 2023 – 2033 ($ Million)

10.6.7.2.       Egypt: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million)

10.6.7.3.       Egypt: Market Size and Forecast, By Therapeutic Area, 2023 – 2033 ($ Million)

10.6.8.      SOUTH AFRICA

10.6.8.1.       South Africa: Market Size and Forecast, By Cell Type, 2023 – 2033 ($ Million)

10.6.8.2.       South Africa: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million)

10.6.8.3.       South Africa: Market Size and Forecast, By Therapeutic Area, 2023 – 2033 ($ Million)

10.6.9.           REST OF MIDDLE EAST & AFRICA

10.6.9.1.        Rest of Middle East & Africa: Market Size and Forecast, By Cell Type, 2023 – 2033 ($ Million)

10.6.9.2.        Rest of Middle East & Africa: Market Size and Forecast, By Therapy Type, 2023 – 2033 ($ Million)

10.6.9.3.        Rest of Middle East & Africa: Market Size and Forecast, By Therapeutic Area, 2023 – 2033 ($ Million)

CHAPTER 12.               Competitive Landscape

12.1.     Competitior Benchmarking 2023

12.2.     Market Share Analysis

12.3.     Key Developments Analysis By Top 5 Companies

12.4.     Market Share Acquisition Strategies: Analysis of Key Approaches Employed by Top Players

CHAPTER 13.               Company Profiles

13.1.     Novartis AG

13.1.1.      Business Overview

13.1.2.      Financial Analysis

13.1.2.1.       Business Segment Revenue, 2020, 2021, 2022, $ Million

13.1.2.2.       Geographic Revenue Mix, 2022 (% Share)

13.1.3.      Product Portfolio

13.1.4.      Recent Development and Strategies Adopted

13.1.5.      SWOT Analysis

13.2.     Gilead Sciences Inc

13.3.     Bristol-Myers Squibb Company

13.4.     Johnson & Johnson Services Inc

13.5.     JCR Pharmaceuticals Co Ltd

13.6.     Tego Science

13.7.     Atara Biotherapeutics

13.8.     Takeda Pharmaceutical Company Limited

13.9.     Bluebird Bio Inc

13.10.  Dendreon Corp

 

Connect to Analyst

Connect to Analyst

Research Methodology

Research Methodology

Related products

Life Science

Track and Trace Solutions Market Analysis and Global Forecast (2021-2028) with COVID Impact Analysis

$4,745.60(Approx. $ 3,475.00)
Track and Trace Solutions Market By Product Type (Hardware Components, Software, Standalone Platforms, Tracking, Tracing and Reporting Solutions), By Application (Serialization Solutions, Medical Devices Serialization Aggregation Solution) and By Geography – COVID-19 Impact Analysis, Post COVID Analysis, Opportunities, Trends and Forecast from 2021 to 2028 Report Code: EB_LS_332| Page: 163| Published Date: March 2021
Add to cart
Quick view
Life Science

Proteinase K Market Analysis and Global Forecast (2020-2027) with COVID Impact Analysis

$4,745.60(Approx. $ 3,475.00)
Proteinase K Market By Type (Natural, Recombinant), Form Factor (Liquid, Powder, Tablet), End User (Bio-Pharmaceutical, Pharmaceutical, Academic and Research Centers, Hospitals, Contract Research Organization, Diagnostic Laboratories) and By Geography – COVID-19 Impact Analysis, Post COVID Analysis, Opportunities, Trends and Forecast from 2020 to 2027 Report Code: EB_LS_451 | Page: 124| Published Date: March 2021
Add to cart
Quick view
Healthcare

Global Healthcare Blockchain Technology Market

$4,745.60(Approx. $ 3,475.00)
Healthcare Blockchain Technology Market By Type (Public and Private) By Application (Clinical Data Exchange & Interoperability, Claims Adjudication & Billing, Supply Chain Management, and Others) By End Use (Hospitals, Healthcare Payers, Healthcare Providers, Pharmaceutical Companies, and Others) and By Geography: Global trends, opportunities and forecast – 2020 to 2026
Add to cart
Quick view
Life Science

Particle Counters Market Analysis and Global Forecast (2020-2028) with COVID Impact Analysis

$4,745.60(Approx. $ 3,475.00)
Particle Counters Market By Product Type (Cleanroom Monitoring, Drinking Water Contamination Monitoring, Aerosol Monitoring and Research, Others), By Type (Airborne Particle Counters, Liquid Particle Counters) and By Geography – COVID-19 Impact Analysis, Post COVID Analysis, Opportunities, Trends and Forecast from 2021 to 2028 Report Code: EB_LS_338| Page: 169 | Published Date : March 2021
Add to cart
Quick view
Life Science

Proteomics Market Analysis and Global Forecast (2021-2028) with COVID Impact Analysis

$4,745.60(Approx. $ 3,475.00)
Proteomics Market By Component (Instruments, Reagents, Services,), By Application (Drug Discovery, Diseases Diagnosis) and By Geography – COVID-19 Impact Analysis, Post COVID Analysis, Opportunities, Trends and Forecast from 2021 to 2028 Report Code: EB_LS_331 | Page: 162 | Published Date: March 2021
Add to cart
Quick view
Healthcare

Global Electroencephalography (EEG) Equipment Market

$4,745.60(Approx. $ 3,475.00)
Electroencephalography (EEG) Equipment Market By Product (EEG Equipment, EEG Accessories) By Application (Diseases Diagnosis, Sleep Monitoring, Anesthesia Monitoring, Trauma & Surgery, Others) By End User (Hospitals, Diagnostic Centers, Surgical Centers, Research Laboratories, Others) and By Geography: Global trends, opportunities and forecast – 2020 to 2026
Add to cart
Quick view
Life Science

Telmisartan Market Analysis and Global Forecast (2021-2028) with COVID Impact Analysis

$4,745.60(Approx. $ 3,475.00)

Telmisartan Market By Indication (Hypertension and Cardiovascular Risk Reduction), By Distribution Channel(Hospital Pharmacies, Drug Stores and Retail Pharmacies, Online Pharmacies) and By Geography – COVID-19 Impact Analysis, Post COVID Analysis, Opportunities, Trends and Forecast from 2021 to 2028

Report Code: EB_LS_313| Page: 164 | Published Date: March 2021
Add to cart
Quick view
Life Science

Cough Syrup Market Analysis and Global Forecast (2021-2028) with COVID Impact Analysis

$4,745.60(Approx. $ 3,475.00)

Cough Syrup Market By Product Type (Combination Drugs, Individuals), By Category(Cough Suppressants, Expectorants) and By Geography – COVID-19 Impact Analysis, Post COVID Analysis, Opportunities, Trends and Forecast from 2021 to 2028

Report Code: EB_LS_317| Page: 165 | Published Date: March 2021
Add to cart
Quick view

Uncover Market Secrets: Get Market Insights in Your Inbox 🚀

Join over 5,000 professionals staying ahead of industry trends. Subscribe to our weekly market research newsletter.

Join our community of industry leaders and stay ahead of the curve. Subscribe now for data-driven market intelligence and strategic recommendations that will set your business on a path to success! Don't miss out on our FREE exclusive insights – sign up today and soar above your competition!🚀

cropped-evolvebi-Logo-2021-1.png
M/S Evolve Business Intelligence C-218, 2nd floor, M-Cube, N.H. – 48, Balitha, Vapi, Valsad- Gujarat
Email: [email protected]

Email: [email protected]

  • Important Links
    • About Evolvebi
    • Competitive Intelligence
    • Become a reseller
    • Contact Us
  • Top Search By Countries Hot
    • United State
    • Europe
    • Asia Pacific
    • Middle East & Africa
    • Latin America

© 2021 - 2023 Evolve Business Intelligence. All rights reserved. Developed by Nectron

Privacy Policy | Terms and Conditions | Cancellation and Refund policy

  • Home
  • About Us
  • Services
  • Market Reports
    • Automotive
      • Component
      • Vehicle
      • Chemical Automotive
      • Technology
      • Freight & Logistics
      • Material
      • Technology
      • Transport Mode
      • Utility
      • Vehicle
    • Chemical and Materials
      • Chemical
      • Advanced Materials
      • Coatings and Additives
      • Composites
      • Paints
      • Textile
    • Aerospace & Defense
      • Marine
      • Security
      • Technology
      • Aircraft Components
      • Aircraft Material
    • Construction & Manufacturing
    • Electronics and Semiconductor
      • Display Technology
      • Electronic Component
      • Electronic Devices
      • Semiconductor
      • Communication Equipment
      • Emerging Technologies
      • Security
      • Sensor & Control
      • Technology
    • Energy and Power
    • Life Science
    • Consumer & Goods
      • Baby products and supplies
      • Beauty & Personal Care
      • Consumer
      • Home Products
    • Information and Communication Technology
      • Emerging Technologies
      • Entertainment Technologies
      • Security
      • Communication
      • Data Center
      • Data Center and Networking
      • Software and Services
      • Technology
  • Competitive Intelligence (CI)
    • Automotive (CI)
    • Chemical and Materials (CI)
    • Construction & Manufacturing (CI)
    • Energy and Power (CI)
    • Electronics and Semiconductor (CI)
    • Healthcare (CI)
    • Information and Communication Technology ICT (CI)
  • Contact Us
We use cookies to improve your experience on our website. By browsing this website, you agree to our use of cookies.
More info Accept
I allow the Site owner to contact me via email/phone to discuss this enquiry. (If you want to know more about the way this site handles the data, then please go through our privacy policy).
Brought to you by WisdmLabs: WordPress Development Experts

Sending...